Research Study

Technically speaking...

Recent studies have shown that an asymptomatic SARS-COV-2 carrier can have up to 100,000,000 copies of the virus per mL in their mouth and expel over 16 infectious doses of virus per minute while talking and active.

Fortunately, SARS-COV-2 is highly susceptible to germicidal UV irradiation; in fact, it is three times more susceptible to UV than common influenza virus. Our Gpurify ultraviolet irradiation delivers an ultraviolet dosage of in excess of 50 mJ/cm2. The photolytic technology contained in the unit was demonstrated to inactivate SARS-CoV-2 virus in direct testing.

Battelle Research Labs performed SARS-CoV-2 bioaerosol elimination testing of the Gpurify photolytic filtration technology - The purpose of the study was to determine effectiveness of the Aerobiotix C-band ultraviolet (UVC) air filtration unit to remove SARS-CoV-2 bioaerosols under challenge conditions with viable virus. Within the limitations of this study, the Aerobiotix unit was successful in removing viable SARS- CoV-2 bioaerosols compared to controls. While the unit is much bigger, the technology and effectiveness are the same.

He is a summary of the study: https://aerobiotix.com/wp-content/uploads/2020/08/SARS-CoV-2-Bioaerosol-Removal-by-the-Aerobiotix-Ultraviolet-Filtration-System.pdf 

 

 

 

Stay connected with our newsletter

Learn more about how our purifiers are proven to kill SARS-Cov-2